The JANUS serum bank.
The on-going JANUS project was initiated by the Norwegian Cancer Society in 1973. The serum bank comprises close to 0.5 million serum samples collected from 170,000 donors. From 2-16 consecutive samples are available from each donor. The sera are stored at -25 degrees C. At regular intervals the JANUS-collection is matched against the files of the Norwegian Cancer Registry. From 1973 to 1991 almost 5000 of the donors have developed some form of cancer. Frozen serum samples collected from a few months to 18 years prior to clinical recognition of their disease are consequently available for research purposes. The aim of the JANUS-project is to search in these premorbid sera for chemical, biochemical, immunological or other changes that might be indicative of cancer development at early stages. Gas chromatography-mass spectrometry and two-dimensional protein electrophoresis have been used to evaluate the stability of the frozen sera. Some recent findings are: CA125 is elevated several months prior to diagnosis of ovarian cancer; serum thyroglobulin may be a preclinical tumour marker in subgroups of thyroid cancer; low level of selenium in serum reflects increased risk of thyroid cancer; and raised antibodies in serum against Epstein-Barr virus is a risk factor for development of Hodgkin's disease. On-going research includes trace elements and cancer, and studies on lipid-profiles, diet and cancer. The serum bank may in principle be used for other purposes, e.g. in environmental studies. Analysis of sequential sera may determine chemical substances in the sera that might reflect differences in exposure to environmental pollutants in the period 1973-1991.
Jellum
E
E
Norwegian Cancer Society, Oslo.
Andersen
A
A
Lund-Larsen
P
P
Theodorsen
L
L
Orjasaeter
H
H
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D015415:Biomarkers / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D001771:Blood Banks; D001798:Blood Proteins / Q000032:analysis*; D001800:Blood Specimen Collection / Q000379:methods; D004784:Environmental Monitoring; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood; D009369:Neoplasms / Q000097:blood* / Q000209:etiology; D009664:Norway; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis; D012643:Selenium / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood; D014131:Trace Elements / Q000097:blood*; D014837:Voluntary Health Agencies
D015295:Antigens, Tumor-Associated, Carbohydrate; D015415:Biomarkers; D014408:Biomarkers, Tumor; D001798:Blood Proteins; D014131:Trace Elements; D012643:Selenium